Based on preclinical data, we designed a phase I/II clinical trial to determine the efficacy and toxicity of doxorubicin followed by paclitaxel in the treatment of advanced breast cancer (either untreated or relapsed after
Giovanni Luca Frassineti, MD
Advertisement
Articles by Giovanni Luca Frassineti, MD
Advertisement
Latest Updated Articles
- Doxorubicin and Paclitaxel (Sequential Combination) in the Treatment
Published: April 1st 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
2
FDA Grants Fast Track Designation to MT-125 in Glioblastoma
3
HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma
4
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
5
